EP3600233A4 - Méthode de traitement d'affections cutanées des paupières - Google Patents

Méthode de traitement d'affections cutanées des paupières Download PDF

Info

Publication number
EP3600233A4
EP3600233A4 EP17902778.4A EP17902778A EP3600233A4 EP 3600233 A4 EP3600233 A4 EP 3600233A4 EP 17902778 A EP17902778 A EP 17902778A EP 3600233 A4 EP3600233 A4 EP 3600233A4
Authority
EP
European Patent Office
Prior art keywords
treatment
skin conditions
eye lids
lids
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP17902778.4A
Other languages
German (de)
English (en)
Other versions
EP3600233A1 (fr
Inventor
Vivi Robyn STAFFORD
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP3600233A1 publication Critical patent/EP3600233A1/fr
Publication of EP3600233A4 publication Critical patent/EP3600233A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88Two- or multipart kits
    • A61K2800/882Mixing prior to application
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP17902778.4A 2017-03-26 2017-03-26 Méthode de traitement d'affections cutanées des paupières Withdrawn EP3600233A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2017/024201 WO2018182562A1 (fr) 2017-03-26 2017-03-26 Méthode de traitement d'affections cutanées des paupières

Publications (2)

Publication Number Publication Date
EP3600233A1 EP3600233A1 (fr) 2020-02-05
EP3600233A4 true EP3600233A4 (fr) 2020-10-21

Family

ID=63678310

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17902778.4A Withdrawn EP3600233A4 (fr) 2017-03-26 2017-03-26 Méthode de traitement d'affections cutanées des paupières

Country Status (5)

Country Link
EP (1) EP3600233A4 (fr)
CN (1) CN110582264B (fr)
CA (1) CA3056919A1 (fr)
MX (1) MX2019011603A (fr)
WO (1) WO2018182562A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200016056A1 (en) * 2018-01-05 2020-01-16 Vivi Robyn Stafford Method of subcutaneous aqueous citric acid injection non-surgical skin tightening excluding orbit

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451572A (en) * 1988-02-26 1995-09-19 Genentech, Inc. Human relaxin formulation
US20050267080A1 (en) * 2004-05-19 2005-12-01 Kolodney Michael S Methods and related compositions for reduction of fat
US20160166695A1 (en) * 2014-12-16 2016-06-16 Eli Lilly And Company Rapid-acting insulin compositions
CA2985171A1 (fr) * 2015-05-08 2016-11-17 Activus Pharma Co., Ltd. Agent aqueux de suspension comprenant des nanoparticules de glucocorticosteroide
EP3299011A1 (fr) * 2016-09-22 2018-03-28 Kyoung Lack Lee Composition hypotonique décomposition de graisse et son procédé de préparation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB815517A (en) * 1955-06-20 1959-06-24 Upjohn Co Dihydro novobiocin, its salts and other derivatives and pharmaceutical compositions containing same
CA2153553A1 (fr) * 1994-07-13 1996-01-14 Hidekazu Suzuki Emulsion stable de lipides
CA2552442A1 (fr) * 2002-12-31 2004-06-30 Avon Products, Inc. Compositions et procede d'administration pour le traitement de rides, fins sillons et de l'hyperhidrose
JP2004292400A (ja) * 2003-03-28 2004-10-21 Ichimaru Pharcos Co Ltd メイラード反応阻害剤及び化粧料組成物又は食品
CA2846382C (fr) * 2004-02-20 2017-09-19 The Hospital For Sick Children Composes a base de manganese destines a l'elastogenese et au traitement de tissu connectif
US20060127468A1 (en) * 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
RU2006146555A (ru) * 2004-05-28 2008-07-20 Шеринг Копрорейшн (Us) Инъецируемые фармацевтические композиции позаконазола со стабилизированными частицами
US20070298005A1 (en) * 2006-06-22 2007-12-27 Marie-Josee Thibault Injectable composition for treatment of skin defects or deformations
AR083847A1 (es) * 2010-11-15 2013-03-27 Novartis Ag Variantes de fc (fragmento constante) silenciosas de los anticuerpos anti-cd40
US20130052244A1 (en) * 2011-08-30 2013-02-28 Mark Weinreb Stem Cell Compositions and Methods
EP2771033A4 (fr) * 2011-10-28 2016-02-17 Integritybio Inc Formulations protéiques contenant des acides aminés
RU2512801C1 (ru) * 2012-10-08 2014-04-10 Ирина Юрьевна Юхман Лечебно-профилактический бальзам для глаз
WO2014201618A1 (fr) * 2013-06-18 2014-12-24 山东省生物药物研究院 Utilisation de gomme de xanthane dans la préparation de produits de beauté injectables
US9744110B2 (en) * 2015-09-29 2017-08-29 Debra Louise Stafford Method of treating conditions of the eyelid

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451572A (en) * 1988-02-26 1995-09-19 Genentech, Inc. Human relaxin formulation
US20050267080A1 (en) * 2004-05-19 2005-12-01 Kolodney Michael S Methods and related compositions for reduction of fat
US20160166695A1 (en) * 2014-12-16 2016-06-16 Eli Lilly And Company Rapid-acting insulin compositions
CA2985171A1 (fr) * 2015-05-08 2016-11-17 Activus Pharma Co., Ltd. Agent aqueux de suspension comprenant des nanoparticules de glucocorticosteroide
EP3299011A1 (fr) * 2016-09-22 2018-03-28 Kyoung Lack Lee Composition hypotonique décomposition de graisse et son procédé de préparation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2018182562A1 *

Also Published As

Publication number Publication date
EP3600233A1 (fr) 2020-02-05
MX2019011603A (es) 2021-08-16
CN110582264B (zh) 2022-11-11
CN110582264A (zh) 2019-12-17
WO2018182562A1 (fr) 2018-10-04
CA3056919A1 (fr) 2018-10-04

Similar Documents

Publication Publication Date Title
EP3426250A4 (fr) Procédés de traitement
EP3390634A4 (fr) Compositions et méthodes pour le traitement de maladies oculaires
EP3716997A4 (fr) Méthodes de traitement avec de l'asparaginase
EP3684342A4 (fr) Procédé de traitement
EP3630101A4 (fr) Méthodes de traitement de maladies
EP3554505A4 (fr) Méthodes de traitement de troubles oculaires
EP3490476A4 (fr) Compositions et méthodes pour le traitement de troubles cutanés
EP3713583A4 (fr) Méthodes et compositions pour le traitement de la peau
EP3213761A4 (fr) Nouveau traitement de la rétine et des nerfs utilisant la laminine
EP3713553A4 (fr) Compositions et méthodes de traitement des maladies oculaires
EP3618923A4 (fr) Système et procédé de traitement de la myopie
EP3209295A4 (fr) Méthodes de traitement de troubles oculaires
EP3599983A4 (fr) Endoscopes et méthodes de traitement
EP3645030A4 (fr) Méthode de traitement
EP3582781A4 (fr) Méthode de traitement
EP3574003A4 (fr) Méthode de traitement
EP3490547A4 (fr) Méthode de traitement de tumeurs.
EP3624819A4 (fr) Procédés de traitement de la dystonie cervicale
EP3600233A4 (fr) Méthode de traitement d'affections cutanées des paupières
EP3302382A4 (fr) Implant pour le traitement d'une affection oculaire
EP3271017A4 (fr) Traitement d'affections cutanées
EP3890780A4 (fr) Procédé de traitement
EP3727376A4 (fr) Méthodes de traitement de l'hypertriglycéridémie
EP3541371A4 (fr) Méthodes de traitement de la cystite interstitielle
EP3658217A4 (fr) Traitement de troubles oculaires

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20191023

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20200918

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 8/34 20060101ALI20200914BHEP

Ipc: A61K 8/365 20060101ALI20200914BHEP

Ipc: A61K 9/08 20060101ALI20200914BHEP

Ipc: A61Q 19/00 20060101ALI20200914BHEP

Ipc: A61K 8/362 20060101AFI20200914BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20210417